Watchman FLX

DEVICE2 trials

Sponsors

Boston Scientific Corporation

Conditions

Atrial FibrillationNon-valvular Atrial Fibrillation

Unknown Phase

Watchman FLX Left Atrial Appendage Closure Device Post Approval Study ( Europe Only)

CompletedNCT02654470

Boston Scientific CorporationNon-valvular Atrial Fibrillation

Start: 2019-07-16End: 2021-09-28Updated: 2021-11-19

Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology

CompletedNCT02702271

Boston Scientific CorporationAtrial Fibrillation

Start: 2018-05-07End: 2021-03-12Updated: 2022-06-14

Related Papers

Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device

Circulation2021-04-06372 citations